轻度创伤性脑损伤后心理健康筛查工具的诊断准确性
本研究为一项整群随机临床试验的二次分析,纳入537例mTBI成人,最终499例有数据,于伤后12周在线完成PHQ-9、GAD-7、PC-PTSD-5,并以视频会议进行的MINI结构化精神诊断访谈(盲法评估)为参照。总体样本中各量表在最佳界值时AUC≥0.80,敏感度0.55–0.94,特异度0.64–0.94。存在持续性脑震荡后症状(PPCS)者AUC(差值0.01–0.13)与特异度(差值5–65个百分点)低于无PPCS者,但PPCS者至少1种精神障碍的患病率高出3–5倍。GAD-7检测PTSD的AUC略优于PC-PTSD-5(0.85 [95%CI 0.80–0.89] vs 0.80 [95%CI 0.72–0.87])。作者认为这些工具可准确筛查mTBI患者的精神健康障碍,未来研究应验证该人群的最佳界值。
要点
- 在499例mTBI成人中,PHQ-9、GAD-7、PC-PTSD-5于伤后12周筛查抑郁、焦虑、PTSD均具较强诊断准确性,最佳界值时AUC≥0.80。
- PHQ-9最佳界值为症状持续超过半数天数且≥5项;GAD-7最佳界值为总分≥7分。
- 存在PPCS者AUC较无PPCS者低0.01–0.13,特异度低5–65个百分点,但至少1种精神障碍患病率高出3–5倍。
- GAD-7检测PTSD的AUC为0.85(95%CI 0.80–0.89),略优于PC-PTSD-5的0.80(95%CI 0.72–0.87)。
- 总体样本敏感度0.55–0.94、特异度0.64–0.94;作者认为这些工具可准确筛查mTBI后精神健康障碍,未来研究应验证最佳界值。
适用人群与场景
- 成人轻度创伤性脑损伤(mTBI)患者,于伤后12周接受筛查。
- 来自整群随机临床试验的二次分析,2021年2月1日至2022年10月25日招募,N=537,最终499例有数据。
- 按国际疾病与统计分类第十版标准分为伴持续性脑震荡后症状(PPCS)与不伴PPCS者。
诊断标准与关键阈值
- PHQ-9最佳界值:症状持续超过半数天数且≥5项。
- GAD-7最佳界值:总分≥7分。
- 以盲法评估的MINI(DSM-5)结构化精神诊断访谈为参照标准,判定重性抑郁发作、焦虑障碍和PTSD。
研究设计与关键结果
- 诊断研究,为整群随机临床试验的二次分析;499/537例有数据,278例(55.7%)为女性,平均(SD)年龄38.8(13.9)岁。
- 总体样本中各筛查问卷在最佳界值时AUC≥0.80,敏感度0.55–0.94,特异度0.64–0.94。
- 伴PPCS者较不伴PPCS者AUC低0.01–0.13、特异度低5–65个百分点,但伴PPCS者至少1种精神障碍的患病率高出3–5倍。
- GAD-7检测PTSD的AUC为0.85(95%CI 0.80–0.89),PC-PTSD-5为0.80(95%CI 0.72–0.87)。
证据类型、等级与局限
- 证据类型:诊断研究,为整群随机临床试验的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,PHQ-9、GAD-7和PC-PTSD-5可准确筛查mTBI患者的精神健康障碍。
- 作者指出,未来研究应验证该人群的最佳检测界值。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Mental health disorders are common after mild traumatic brain injury (mTBI) and likely exacerbate postconcussive symptoms and disability. Early detection could improve clinical outcomes, but the accuracy of mental health screening tools in this population has not been well established.
OBJECTIVE: To determine the diagnostic accuracy of the Patient Health Questionnaire-9 (PHQ-9), Generalizaed Anxiety Disorder-7 (GAD-7), and Primary Care PTSD (Posttramatic Stress Disorder) Screen for Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) (DSM-5) (PC-PTSD-5) in adults with mTBI.
DESIGN, SETTING, AND PARTICIPANTS: This diagnostic study was performed as a secondary analysis of a cluster randomized clinical trial. Self-report mental health screening tools (PHQ-9, GAD-7, and PC-PTSD-5) were administered online 12 weeks after mTBI and compared against a structured psychodiagnostic interview (Mini-International Neuropsychiatric Interview for DSM-5 (MINI) over videoconference at the same time. Adults with mTBI (N = 537) were recruited from February 1, 2021, to October 25, 2022.
MAIN OUTCOMES AND MEASURES: Presence of a major depressive episode, anxiety disorders, and PTSD were determined by a blinded assessor with the MINI. Diagnostic accuracy statistics were derived for the PHQ-9, GAD-7, and PC-PTSD-5. Findings were disaggregated for participants with and without persistent postconcussion symptoms (PPCS) by International and Statistical Classification of Diseases, Tenth Revision criteria.
RESULTS: Data were available for 499 of 537 trial participants, 278 (55.7%) of whom were female; the mean (SD) age was 38.8 (13.9) years. Each screening questionnaire had strong diagnostic accuracy in the overall sample for optimal cut points (area under the curve [AUC], ≥0.80; sensitivity, 0.55-0.94; specificity, 0.64-0.94). The AUC (difference of 0.01-0.13) and specificity (difference, 5-65 percentage points) were lower in those with PPCS present compared with PPCS absent, but the prevalence of at least 1 mental health disorder was 3 to 5 times higher in patients with PPCS present. The GAD-7 had slightly better performance than the PC-PTSD-5 for detecting PTSD (AUC, 0.85 [95% CI, 0.80-0.89] vs 0.80 [95% CI, 0.72-0.87]). The optimal cutoff on the PHQ-9 was 5 or more symptoms experienced on more than half of days; on the GAD-7, a total score of at least 7.
CONCLUSIONS AND RELEVANCE: The findings of this diagnostic study suggest that the PHQ-9, GAD-7 and PC-PTSD-5 accurately screen for mental health disorders in patients with mTBI. Future research should corroborate optimal test cutoffs for this population.
参考来源
- Gitaari M, Mikolic A, Panenka WJ, et al. Diagnostic Accuracy of Mental Health Screening Tools After Mild Traumatic Brain Injury. JAMA Netw Open. 2024. PMID: 39042406. doi:10.1001/jamanetworkopen.2024.24076
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。